Portfolio Asset N°2

BIORESPX

A new family of functional excipient molecules developed in collaboration with researchers at the EPFL. Those molecules can protect and enhance the activity of biological drugs (particularly antibody drugs) and thus make possible the direct delivery of biological drugs in liquid formulations directly into the respiratory tract.

More information coming soon.